View in EDS HTML Full Text PDF Full Text

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.
Authors: Alhalabi, Omar1 (AUTHOR), Gouda, Mohamed A.2 (AUTHOR), Milton, Denái R.3 (AUTHOR), Momin, Hassan Ahmed2 (AUTHOR), Yilmaz, Bulent2 (AUTHOR), Stephen, Bettzy2 (AUTHOR), Ejezie, Chinenye Lynette2 (AUTHOR), Moyers, Justin Tyler4 (AUTHOR), Gurses, Serdar A.2 (AUTHOR), How, Jeffrey2 (AUTHOR), Fu, Siqing2 (AUTHOR), Rodon, Jordi2 (AUTHOR), Hong, David S.2 (AUTHOR), Piha‐Paul, Sarina A.2 (AUTHOR), Subbiah, Vivek2 (AUTHOR), Elena Dumbrava, Ecaterina2 (AUTHOR), Karp, Daniel D.2 (AUTHOR), Janku, Filip2 (AUTHOR), Meric‐Bernstam, Funda2 (AUTHOR), Tannir, Nizar M.1 (AUTHOR) ntannir@mdanderson.org
Source: Cancer Medicine. Feb2025, Vol. 14 Issue 4, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.70280